Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by StockscoutXon Jul 06, 2021 9:52am
116 Views
Post# 33498381

RE:RE:Anybody see anything at all...

RE:RE:Anybody see anything at all..."Three (3) analysts have set price targets for this stock anywhere between $1.08 and $14.00+"? Based on what? Opinions? Wishful thinking? Flawed data analysis? None of their past forcasts have really panned out. They have a bad accuracy rate in predicting where StageZero SP will be headed so far.

Face the fact. If the stock market sees something import it will rush in like a huge tide and bring the SP to heights never seen before but there will be none of that in the forseeable months ahead. 


gojotv! wrote: Don't you know about the three (3) analysts who have set price targets for this stock anywhere between $1.08 and $14.00+?
To say nothing of insiders' astonishment at the low share price, which is in contradiction to their revenue forecasts?
Pay attention, or you might miss something...


Lithlow wrote: turning this boat around soon? (Like in half a year ish?)

Its a paaaaain to see the general stock market ROAR while we are sitting ducks with this.

Screew the financials, the general stock market will not care if we get 2,3,4 million and we are EBITDADADA whatever positive maaan.

See you in Christmas, when this MIGHT be 0.70 again.


Have a good summer.




<< Previous
Bullboard Posts
Next >>